- Who We Are
- What We Do
- How To Help
- Contact Us
Two teams of former grantees will receive the Foundation’s first Collaborative Grant Awards. Stephen D. Nimer, M.D., Chairman of the Medical Advisory Board announced the grants totaling $800,000 at this year’s Third Annual Medical Symposium and Luncheon. Each team will receive $400,000 over two years.
Ari Melnick, M.D. of Weill Cornell Medical College will work alongside fellow New York colleague Ross Levine, M.D. of Memorial Sloan-Kettering Cancer Center and Chuan He, Ph.D. from The University of Chicago. Their study, entitled “Decoding the hydroxymethylome of IDH and TET mutant acute leukemias,” will look to identify the molecular cause of a new type of acute myelogenous leukemia. To learn more about Melnick's lab, visit his site here.
Anthony Letai, M.D. of Boston’s Dana-Farber Cancer Institute will work with Sloan-Kettering’s Scott Armstrong, M.D. on a project were they propose “a completely novel approach to identifying the chemotherapy resistant subsets in [acute myelogenous] leukemia patient samples, identifying the mechanisms making them resistant to chemotherapy, and targeting those mechanisms.” Click here to read a feature on Letai's award in Boston's Medfield Press.
Of the eleven submitted applications, two were selected for funding by the Foundation's Medical Advisory Board. Nimer, director of the Sylvester Comprehensive Cancer Center remarked, “What is particularly exciting about these new collaborative grants is that they not only prove the value of the initial investment, they bring scientists and institutions together to significantly accelerate and broaden the impact of their work.” The Foundation gratefully acknowledges the generous support of the Marc Rich Foundation for making this new grant possible.